The worst thing ever would be if the stuff that is supposed to be good for you actually wasn’t good for you–and could actually kill you. While the New York Post isn’t exactly known for their patience, they did decide to use the headline “Your Oatmeal May Be Killing You” after reports came out in the New York Times New York Times stating that testing found traces of “glyphosate in some Quaker Oats oatmeal.” Thus begins the so-called “Oatmeal Lawsuit.”
For those that don’t know, glyphosate is a harmful chemical and can kill you in mass quantities. According to the article in the Times, the chemical was “detected in the oatmeal falls well below the limit set by federal regulators for human consumption….Since oats require less herbicide spray than many other grains, there is less risk of pollutants and groundwater contamination.” The result of this is the “oatmeal lawsuit, “a class-action claim where the plaintiff is seeking $5 million in damages, according to the New York Post. The claim points out that the “100% Natural” claim is actually “‘false, deceptive and misleading,’ because the company uses…glyphosate in processing its oats.”
Obviously this case falls under a number of areas and will be interesting to watch from a product liability and false advertising level. Additionally, the presence of a harmful chemical could bring other agencies and regulatory groups into the mix. This venerable company, founded by Ferdinand Schumacher in Akron, OH in 1850 has certainly been around for awhile and has seen worse–but it certainly can’t exactly help their image and their market share in the ever-growing oatmeal market.
Two new recent lawsuits were filed in New Jersey federal court against giant Johnson & Johnson, who face allegations that users of its diabetes drug, Invokana, developed kidney damage and heart disease. These revelations include claims by defendants who say they suffered kidney damage after being prescribed Invokana for diabetes. One patient actually suffered a stroke.
According to New Jersey Law Journal, the suit includes claims for “failure to warn, defective manufacturing, breach of express warranty, breach of warranty of fitness for everyday use, negligence, breach of implied warranty, fraudulent misrepresentation, negligent misrepresentation, fraudulent concealment and fraud.”
Background on Invokana Lawsuits
The U.S. Food and Drug Administration (FDA) approved the drug in 2013 for treatment of Type 2 diabetes. Two years later, the FDA issued a warning about Invokana and Invokamet stating that they may lead to diabetic ketoacidosis – a serious condition in which the body produces high levels of blood acids known as ketones. An analysis of incidents reported to the FDA shows patients taking Invokana for diabetes are several times more likely to report kidney disease than those taking other types of diabetes treatment, the complaints allege.
Johnson & Johnson Invokana History
According to court papers, Invokana made Johnson & Johnson $278 million in the first quarter of 2015, so clearly they have much at stake. A statement from Johnson & Johnson spokeswoman Kaitlin Meiser said: “Invokana is an important medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. With real world experience that includes more than five million prescriptions to date, we are confident in the overall safety profile of Invokana. The company remains committed to aggressively defending against allegations made in these lawsuits.”
Medical Claim Legal and Lawsuits Against Johnson & Johnson
Our team of lawyers has worked on medical claim lawsuits against firms like Johnson & Johnson and will work to get you the attention and claims you deserve. Again, MedicalClaimLegal does not get compensated, unless you do.